“By combining Allozymes technological capabilities with Syensqo’s application and market access expertise, we are poised to create groundbreaking solutions that will not only benefit the home and personal care market but also contribute to a more sustainable future,” Thomas Canova, head of Renewable Materials & Biotechnology growth platform at Syensqo, said in a press statement.
The pact shortly follows Syensqo’s acquisition of South Korean ceramides specialist JinYoung Bio.